Company Overview

Update
Status:
Acquired by C. R. Bard
Founders:
James Drake, Donald Sturtevant
Headquarters:
Minneapolis, MN
Funding:
$115k
Categories:
Biotechnology

Medafor develops novel hemostatic technology and absorbable hemostats called MPH(R), which accelerates the normal blood clotting process.

Description

Update

Medafor, Inc. is a medical device company that has developed and commercialized a patented hemostatic agent that has been shown to enhance and accelerate the normal blood clotting process. Medafor’s MPH technology is unparalleled in terms of safety, efficacy, and cost.

Current Team (1)

Update

Funding Rounds (2) - $115k

Update

Offices/Locations (1)

Update
  • Office

    2700 Freeway Boulevard,

    Suite 800

    Minneapolis, MN 55430

    USA

Images (1)

Update
  • 910356b46588a6342632b0017a1d58dd